CAS 1416324-85-0

CU-CPT22

CAS : 1416324-85-0

CU-CPT22: first TLR1/2 complex probe, binds at TLR1/2 interface (IC50=0.58μM), inhibits Pam3CSK4 binding (Ki=0.41μM).

Formule : C₁₉H₂₂O₇

Degré de pureté : 98.66% - 99.80%

Couleur et forme : Solid

Masse moléculaire : 362.37

Ref: TM-T15020

5H-Benzocycloheptene-8-carboxylic acid, 3,4,6-trihydroxy-2-methoxy-5-oxo-, hexyl ester

CAS : 1416324-85-0

Formule : C₁₉H₂₂O₇

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 362.3738

Ref: IN-DA00A0MW

Hexyl 3,4,6-Trihydroxy-2-Methoxy-5-oxo-5H-Benzo[7]Annulene-8-Carboxylate

CAS : 1416324-85-0

Hexyl 3,4,6-Trihydroxy-2-Methoxy-5-oxo-5H-Benzo[7]Annulene-8-Carboxylate

Degré de pureté : 97%

Masse moléculaire : 362.37g/mol

Ref: 54-OR1023967

CU-CPT22

CAS : 1416324-85-0

CU-CPT22

Degré de pureté : ≥98%

Masse moléculaire : 362.37g/mol

Ref: 54-BUP04026

CU CPT 22

CAS : 1416324-85-0

CU CPT 22 is a synthetic peptide that is structurally similar to the human cytokine TNF-α. It has the same biological activity as TNF-α and is able to bind with high affinity to the TNF receptor, TNFR1. CU CPT 22 has been shown to be an effective treatment for inflammatory diseases by reducing inflammation through its interaction with TNFR1. This drug can also inhibit protein synthesis in cells, which may lead to cell death. CU CPT 22 also has a role in osteogenesis and cellular differentiation and can induce toll-like receptor 4 (TLR4) expression on macrophages, which may play a role in autoimmune diseases.

Formule : C₁₉H₂₂O₇

Degré de pureté : Min. 95%

Masse moléculaire : 362.37 g/mol

Ref: 3D-RGC32485